课题基金 / 基金详情

PHARMACY INTERVENTIONS FOR POLYPHARMACY IN THE ELDERLY

PHARMACY INTERVENTIONS FOR POLYPHARMACY IN THE ELDERLY
对老年人进行多种药物治疗的药物干预
批准号:
3119988
负责人:
JOSEPH T HANLON
金额:
$15.05万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1990
资助国家:
美国
项目状态:
已结题
起止时间:
1990-03-01 至 1993-02-28

项目摘要

项目成果

JOSEPH T HANLON的其他基金

相似基金

相关文献

中文摘要
翻译
本研究的目的是确定干预措施是否 可以改善药物使用模式, 老年门诊人群多药治疗。 通过增强 患者依从性和减少不适当的处方, 老年患者的医疗保健可以得到改善。 两 需要评估的具体干预措施是:(1)提供 (2)为患者提供药物治疗; 关于初级保健药物治疗方案的教育反馈 医生 研究设计的意义在于它将是第一个 一项针对高危人群的随机对照试验, 也就是说,患者年龄超过70岁, 三种药物。 结果指标,如服用的药物, 药物不良反应,依从性,卫生服务利用, 药物费用和健康状况,将在 在实施干预措施后。 最终目标是提高保健质量 老年患者,并评估成本效益的 门诊环境中的临床药师。
英文摘要
The purpose of this study is to determine whether interventions by a clinical pharmacist can improve drug use patterns in a elderly ambulatory population with polypharmacy. By enhancing patient compliance and reducing inappropriate prescribing, the health care of older patients could be improved. The two specific interventions to be evaluated are (1) the provision of medication counseling to patients and (2) the provision of educational feedback concerning drug regimens to primary care physicians. The research design is significant in that it will be the first randomized controlled trial to focus on a high risk population, that is, patients older than 70 years of age and on more than three medications. Outcome measures, such as medications taken, adverse drug reactions, compliance, health service utilization, medication costs, and health status, will be assessed before and after the implementation of the interventions. The ultimate objectives are to enhance the quality of health care of older patients and to assess the cost-effectiveness of a clinical pharmacist within an ambulatory setting.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
UPITT Program for Pharmaceutical Outcomes Research in Aging
Racial Disparities in Older Adults: Impact of Medicare Part D
UPITT Program for Pharmaceutical Outcomes Research in Aging
UPITT Program for Pharmaceutical Outcomes Research in Aging
海外基金